サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1624396

セルソーティングの世界市場規模：製品・サービス別、技術別、エンドユーザー別、地域別、範囲および予測

Global Cell Sorting Market Size By Product and Services, By Technology, By End- Users, By Geographic Scope and Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
セルソーティングの世界市場規模：製品・サービス別、技術別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年11月13日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

セルソーティングの市場規模と予測

セルソーティングの市場規模は、2023年に2億5,983万米ドルと評価され、2024年から2031年にかけてCAGR 6.81％で成長し、2031年には4億4,013万米ドルに達すると予測されています。セルソーティングは、混合集団から物理的・生化学的性質に応じて特定のタイプの細胞を分離・単離する複雑な実験技術です。この方法は、生物学的研究、臨床診断、医薬品開発を含む様々なアプリケーションに不可欠です。様々な応用において重要であり、研究や治療法を大きく前進させる。基礎研究において、セルソーティングは異種材料から特定の細胞集団を分離するために使用され、科学者は細胞メカニズム、遺伝子発現、細胞活性を深く研究することができます。

セルソーティング技術は、個別化医療や治療技術の向上においてますます重要な役割を果たすと予測されています。将来のセルソーターは、マイクロ流体工学と自動化が進むにつれて、より高い解像度、より速い処理速度、より高い精度を提供するようになると思われます。これにより、個々の細胞の不均一性を知ることで、より効果的で個別化された治療につながる単一細胞分析のような分野での技術が向上します。

世界のセルソーティング市場力学

世界のセルソーティング市場を形成している主な市場力学は以下の通り：

主な市場促進要因

バイオテクノロジーとゲノミクスの進歩

バイオテクノロジーとゲノミクスの急速な進歩は、セルソーティング市場の主要促進要因です。シングルセルゲノミクスとプロテオミクスは、遺伝子発現、遺伝子変異、タンパク質相互作用を個々の細胞レベルで評価するために正確な細胞分離を必要とする技術です。

個別化医療への注目の高まり

個別化医療とオーダーメイド治療への注目の高まりは、セルソーティングビジネスに大きな影響を与えています。個別化医療は、個々の患者の遺伝的・分子的プロファイルを理解し、治療をより個別化することに基づいています。

がん研究と免疫療法の増加

がん研究と免疫療法への重点の高まりは主要な市場促進要因です。がん研究プログラムの拡大、免疫療法や細胞ベースの治療に焦点を当てた臨床試験の増加は、これらの複雑でハイスループットなアプリケーションをサポートできるセルソーティング技術に対する強い需要を生み出しています。

主な課題

サンプル調製と品質：

セルソーティングの成功は、高品質のサンプル調製にかかっています。サンプル調製が不十分だと、ソーティングが正しく行われず、結果が損なわれる可能性があります。細胞の凝集、残渣、サンプル量の不一致はすべて、ソーティングプロセスの効率と精度に影響を及ぼします。一貫した高品質のサンプル調製を維持することは、大変な作業です。

データ管理と分析：

セルソーティングは大量のデータを生成し、それを処理し検査しなければならないです。これには、データを選別するだけでなく、得られた生物学的データを解釈し、適切な結論を導き出す必要があります。このようなデータの処理と解析は、高度なソフトウェアと処理リソースを必要とし、困難な場合があります。

バイオテクノロジーとゲノミクスの進歩：

バイオテクノロジーと遺伝学の急速な進歩は、セルソーティング市場の主要な促進要因です。研究および臨床環境における正確な細胞分析および分離に対する要求の高まりが、洗練されたセルソーティング技術に対する需要を押し上げています。シングルセルゲノミクスやトランスクリプトミクスのような技術は、細胞の活動や多様性に関する詳細な洞察を提供するために、高解像度のセルソーティングを必要とします。

主要動向：

セルソーター技術の進歩：

セルソーター技術の革新が市場を前進させています。最新のセルソーターは現在、高速ソーティング、感度の向上、マルチパラメーター分析などの高度な機能を備えています。マイクロ流体ベースのソーターとデジタル液滴ソーティングは、複雑な細胞集団のより正確で効率的な分離を可能にすることで、この分野に変革をもたらしつつあります。

個別化医療への需要の高まり：

個別化医療の推進はセルソーティング市場に大きな影響を与えています。セルソーティングは、バイオマーカーの発見や細胞レベルでの疾患メカニズムの解明など、オーダーメイド治療薬の開発に不可欠です。

幹細胞研究におけるアプリケーションの増加

幹細胞研究はセルソーティング市場成長の重要な促進要因です。幹細胞を正確に選別・精製する能力は、幹細胞の生物学を理解し、幹細胞を用いた治療法を開発するために不可欠です。再生医療が進歩するにつれ、幹細胞を分離・評価するための高度なセルソーティング技術の重要性が増しています。

目次

第1章 世界のセルソーティング市場のイントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界のセルソーティング市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 セルソーティングの世界市場：製品・サービス別

  • 概要
  • セルソーティング試薬と消耗品
  • セルソーティングサービス
  • セルソーター

第6章 セルソーティングの世界市場：技術別

  • 概要
  • 蛍光ベース液滴セルソーティング
  • ジェットインエアセルソーティング
  • キュベットベースセルソーティング
  • 磁気活性化セルソーティング（MACS）
  • マイクロ電気機械システム（MEMS）-マイクロ流体工学

第7章 セルソーティングの世界市場：エンドユーザー別

  • 概要
  • 調査機関
  • 医学部および学術機関
  • 製薬・バイオテクノロジー企業
  • 病院および臨床検査機関

第8章 セルソーティングの世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 世界のセルソーティング市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展戦略

第10章 企業プロファイル

  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.（A Subsidiary of Danaher Corporation）
  • Bio-Rad Laboratories, Inc.
  • Sony Biotechnology Inc.（A Wholly Owned Subsidiary of Sony Corporation of America）
  • MiltenyiBiotec GmbH
  • Affymetrix, Inc.（A Thermo Fisher Scientific Company）
  • SysmexPartec GmbH（A Subsidiary of Sysmex Corporation）
  • On-Chip Biotechnologies Co., Ltd.
  • Cytonome/St, LLC
  • Union Biometrica, Inc

第11章 主な発展

  • 製品の上市／開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

  • 関連調査
目次
Product Code: 24157

Cell Sorting Market Size And Forecast

Cell Sorting Market Size was valued at USD 259.83 Million in 2023 and is projected to reach USD 440.13 Million by 2031, growing at a CAGR of 6.81% from 2024 to 2031. Cell sorting is a complex laboratory technique that separates and isolates specific types of cells from a mixed population depending on their physical and biochemical properties. This method is critical for a variety of applications including biological research, clinical diagnostics, and pharmaceutical development. It is critical in a variety of applications, greatly advancing research and therapeutic practices. In fundamental research, cell sorting is used to isolate certain cell populations from heterogeneous materials allowing scientists to explore cellular mechanisms, gene expression, and cell activity in depth.

Cell sorting technology is projected to play an increasingly important role in personalized medicine and enhanced therapeutic techniques. Future cell sorters will provide higher resolution, faster processing rates, and greater precision as microfluidics and automation progress. This will improve skills in areas like single-cell analysis where knowing the heterogeneity of individual cells can lead to more effective and personalized treatments.

Global Cell Sorting Market Dynamics

The key market dynamics that are shaping the global Cell Sorting Market include:

Key Market Drivers:

Advances in Biotechnology and Genomics

: The rapid advancement of biotechnology and genomics is a major driver of the Cell Sorting Market. Single-cell genomics and proteomics are techniques that need exact cell separation to evaluate gene expression, genetic variants, and protein interactions at the individual cell level.

Growing Focus on Personalized Medicine:

The growing focus on personalized medicine and tailored therapeutics is having a substantial impact on the cell sorting business. Personalized medicine is based on understanding individual patients' genetic and molecular profiles to better personalize treatments.

Increase in Cancer Research and Immunotherapy

: Increased emphasis on cancer research and immunotherapy is a major market driver. The expansion of cancer research programs as well as the increasing number of clinical trials focusing on immunotherapy and cell-based treatments creates a strong demand for cell-sorting technologies capable of supporting these complicated and high-throughput applications.

Key Challenges:

Sample Preparation and Quality:

Successful cell sorting is dependent on high-quality sample preparation. Poorly prepared samples can result in incorrect sorting and compromised results. Cell aggregation, debris, and sample volume discrepancies can all have an impact on how efficiently and accurately the sorting process works. Maintaining consistent and high-quality sample preparation is a considerable task.

Data Management and Analysis:

Cell sorting generates large volumes of data that must be handled and examined. This requires not only sorting data but also interpreting the ensuing biological data to draw relevant conclusions. Handling and analyzing this data can be difficult necessitating advanced software and processing resources.

Advancements in Biotechnology and Genomics:

Rapid advances in biotechnology and genetics are a key driver of the Cell Sorting Market. The growing requirement for precise cell analysis and separation in research and clinical settings is driving up demand for sophisticated cell sorting technologies. Techniques such as single-cell genomics and transcriptomics necessitate high-resolution cell sorting to provide detailed insights into cellular activities and diversity.

Key Trends:

Cell Sorter Technology Advancements:

Innovations in cell sorter technology are propelling the market forward. Modern cell sorters now have advanced features such as high-speed sorting, increased sensitivity, and multi-parameter analysis. Microfluidic-based sorters and digital droplet sorting are transforming the discipline by enabling more precise and efficient separation of complicated cell populations.

Increased Demand for Personalized Medicine:

The push for personalized medicine has a substantial impact on the Cell Sorting Market. Cell sorting is critical for finding biomarkers and understanding disease mechanisms at the cellular level both of which are necessary for the development of customized therapeutics.

Rising Applications in Stem Cell Research

: Stem cell research is a significant driver of growth in the Cell Sorting Market. The ability to accurately sort and purify stem cells is essential for understanding their biology and creating stem cell-based therapeutics. As regenerative medicine improves, sophisticated cell sorting technologies to isolate and evaluate stem cells become increasingly important.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cell Sorting Market Regional Analysis

Here is a more detailed regional analysis of the global Cell Sorting Market:

North America:

The North American region dominates the global Cell Sorting Market owing mostly to significant investments in R&D and a strong healthcare infrastructure. This dominance is strengthened by the presence of large industry companies and sophisticated technological skills in the region. Significant funding for life sciences research is a key driver of the North American Cell Sorting Market.

According to the National Institutes of Health (NIH), the world's largest public supporter of biomedical research, the budget for fiscal year 2023 is USD 47.5 Billion, up USD 2.5 Billion from 2022. This large grant directly supports research initiatives that use cell sorting methods. The California Institute for Regenerative Medicine (CIRM), the largest state-funded stem cell organization in the United States, has provided over USD 2.9 Billion in grants since its founding, promoting research that mainly relies on cell sorting technology.

Furthermore, the Alliance for Regenerative Medicine reports that as of 2021, there were over 1,085 regenerative medicine enterprises worldwide, with a sizable proportion situated in North America. This concentration of research and development activities in regenerative medicine and stem cell therapies drives demand for improved cell sorting solutions in the region cementing North America's dominance in the worldwide Cell Sorting Market.

Asia Pacific:

The Asia Pacific region is having the highest growth in the Cell Sorting Market owing mostly to rapid advances in biotechnology and increased spending in healthcare research & development. Countries such as China, Japan, and India have exceptionally rapid growth. The rising frequency of chronic diseases as well as the resulting demand for enhanced diagnosis and treatment approaches are significant drivers of the Cell Sorting Market in Asia Pacific.

According to the World Health Organization (WHO), noncommunicable illnesses cause 71% of all deaths worldwide with Asia Pacific countries bearing a disproportionate burden. According to China's National Cancer Center, 10.7 million new cancer cases were reported in 2020. This high illness burden is driving investments in cell-based research and therapeutics resulting in increased demand for cell-sorting technology.

Global Cell Sorting Market: Segmentation Analysis

The Global Cell Sorting Market is segmented based on Product and Services, Technology, End-Users, and Geography.

Cell Sorting Market, By Product and Services

  • Cell Sorting Reagents and Consumables
  • Cell Sorting Services
  • Cell Sorters

Based on Products and Services, the Global Cell Sorting Market is bifurcated into Cell Sorting Reagents and Consumables, Cell Sorting Services, and Cell Sorters. In the global Cell Sorting Market, cell sorters are the dominant product and service segment. This dominance is due to the essential role cell sorters play in enabling researchers and clinicians to separate and analyze specific cell populations with high precision. Advances in technology have led to the development of more sophisticated cell sorters offering improved accuracy, speed, and functionality which are critical for applications in research, diagnostics, and therapeutic development.

Cell Sorting Market, By Technology

  • Fluorescence-Based Droplet Cell Sorting
  • Jet-In-Air Cell Sorting
  • Cuvette-Based Cell Sorting
  • Magnetic-Activated Cell Sorting (MACS)
  • Micro-Electromechanical Systems (MEMS) - Microfluidics

Based on Technology, the Global Cell Sorting Market is bifurcated into Fluorescence-Based Droplet Cell Sorting, Jet-In-Air Cell Sorting, Cuvette-Based Cell Sorting, Magnetic-Activated Cell Sorting (MACS), and Micro-Electromechanical Systems (MEMS) - Microfluidics. In the global Cell Sorting Market, fluorescence-based droplet cell sorting is the dominant technology. This dominance is attributed to its high efficiency and precision in separating cells based on fluorescence markers. Fluorescence-based systems can analyze multiple parameters simultaneously allowing for detailed cell characterization and sorting with high purity. This technology is widely used in research, clinical diagnostics, and drug development due to its ability to handle complex samples and provide high-resolution results.

Cell Sorting Market, By End-Users

  • Research Institutions
  • Medical Schools and Academic Institutions
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinical Testing Laboratories

Based on End-Users, the Global Cell Sorting Market is bifurcated into Research Institutions, Medical Schools and Academic Institutions, Pharmaceutical and Biotechnology Companies, and Hospitals and Clinical Testing Laboratories. Pharmaceutical and biotechnology companies are the dominant end-users in the global Cell Sorting Market. This dominance stems from the crucial role cell sorting plays in drug development, personalized medicine, and cellular therapies. These companies utilize cell sorting technology to isolate and analyze specific cell populations which is essential for developing targeted therapies and understanding disease mechanisms.

Cell Sorting Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Rest of the World

Based on Geography, the Global Cell Sorting Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and the Rest of the World. North America is the dominant region in the global Cell Sorting Market. This dominance is attributed to the region's advanced healthcare infrastructure, significant investment in research and development, and high adoption rates of cutting-edge technologies. North America, particularly the United States, hosts numerous leading biotechnology firms, academic institutions, and research organizations that drive demand for advanced cell sorting technologies.

Key Players

  • The "Global Cell Sorting Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Becton, Dickinson and Company, Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc., Sony Biotechnology, Inc. (A Wholly Owned Subsidiary of Sony Corporation of America), MiltenyiBiotec GmbH, Affymetrix, Inc. (A Thermo Fisher Scientific Company), SysmexPartec GmbH (A Subsidiary of Sysmex Corporation), On-Chip Biotechnologies Co., Ltd., Cytonome/St, LLC, Union Biometrica, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Cell Sorting Market Key Developments

  • In May 2023, BD, a medical technology company, introduced new cell sorting equipment with two revolutionary technologies. This allows scientists to find comprehensive information about cells that were previously invisible in typical flow cytometry research.
  • In January 2023, Thermo Fisher Scientific announced that the Bigfoot Spectral Cell Sorter would be available in India. The first-of-its-kind cell sorting Technology combines traditional sorting with spectral sorting and analysis to give simple, high-speed cell sorting.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CELL SORTING MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CELL SORTING MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CELL SORTING MARKET, BY PRODUCT AND SERVICES

  • 5.1 Overview
  • 5.2 Cell Sorting Reagents and Consumables
  • 5.3 Cell Sorting Services
  • 5.4 Cell Sorters

6 GLOBAL CELL SORTING MARKET, BY TECHNOLOGY

  • 6.1 Overview
  • 6.2 Fluorescence-Based Droplet Cell Sorting
  • 6.3 Jet-In-Air Cell Sorting
  • 6.4 Cuvette-Based Cell Sorting
  • 6.5 Magnetic-Activated Cell Sorting (MACS)
  • 6.6 Micro-Electromechanical Systems (MEMS) - Microfluidics

7 GLOBAL CELL SORTING MARKET, BY END USER

  • 7.1 Overview
  • 7.2 Research Institutions
  • 7.3 Medical Schools and Academic Institutions
  • 7.4 Pharmaceutical and Biotechnology Companies
  • 7.5 Hospitals and Clinical Testing Laboratories

8.GLOBAL CELL SORTING MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL CELL SORTING MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Becton, Dickinson and Company
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Bio-Rad Laboratories, Inc.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Sony Biotechnology Inc. (A Wholly Owned Subsidiary of Sony Corporation of America)
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 MiltenyiBiotec GmbH
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Affymetrix, Inc. (A Thermo Fisher Scientific Company)
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 SysmexPartec GmbH (A Subsidiary of Sysmex Corporation)
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 On-Chip Biotechnologies Co., Ltd.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Cytonome/St, LLC
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Union Biometrica, Inc
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research